Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression

Abstract The clinical efficacy of immune checkpoint blockade (ICB) therapy is significantly compromised in the metabolically disordered tumor microenvironment (TME), posing a formidable challenge that cannot be ignored in current antitumor strategies. In this study, TME‐responsive nanoparticles (HMP...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mengna Wang, Yuhong Liu, Yanshi Li, Tao Lu, Min Wang, Zhaobo Cheng, Lin Chen, Tongling Wen, Min Pan, Guohua Hu
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Advanced Science
Subjects:	chemodymic therapy immunosuppression indoleamine 2,3‐dioxygenase 1 KYN/TRP metabolism
Online Access:	https://doi.org/10.1002/advs.202405845
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
by: Yuwen Sheng, et al.
Published: (2025-01-01)

Effect of Exogenous of Transforming Growth Factor-β1 on Pregnancy Outcome in Mice with Recurrent Pregnancy Loss by Persistent Enhancement of Placental Tissue Indoleamine 2,3-Dioxygenase Expression
by: Xinghui Wen, et al.
Published: (2025-01-01)

Optimizing the thermostability of triketone dioxygenase for engineering tolerance to mesotrione herbicide in soybean and cotton
by: Stephen M. G. Duff, et al.
Published: (2025-02-01)

Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
by: Vadim V. Chikin, et al.
Published: (2024-12-01)

Non-trivial uses of melatonin: Its effects on sleep, jet lag, obesity, migraine, and gastrointestinal disorders
by: Jakub Wirkijowski, et al.
Published: (2025-02-01)

Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01)

Polymorphisms in immunosuppression-related genes are associated with AML
by: Mingying Li, et al.
Published: (2025-02-01)

Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression
by: Yingqi Yang, et al.
Published: (2025-01-01)

Immunosuppressive therapy and nutritional diseases of patients after kidney transplantation: a systematic review
by: Aleksandra Anna Kajdas, et al.
Published: (2025-01-01)

Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer
by: Yaojun Ren, et al.
Published: (2025-02-01)

Immunosuppressants in modern approaches to treatment of inflammatory bowel diseases
by: O. B. Schukina, et al.
Published: (2013-05-01)

Enhanced effect of the immunosuppressive soluble HLA-G2 homodimer by site-specific PEGylation
by: Chisato Yamada, et al.
Published: (2025-01-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Protopanaxadiol manipulates gut microbiota to promote bone marrow hematopoiesis and enhance immunity in cyclophosphamide‐induced immunosuppression mice
by: Yuru Cao, et al.
Published: (2023-04-01)

Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
by: Sanchari Paul, et al.
Published: (2025-12-01)

Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppression
by: Shankar Suman, et al.
Published: (2025-01-01)

Cancer incidence and the influence of immunosuppressive agents in Korean patients with systemic lupus erythematosus: a retrospective cohort study
by: Soo-Kyung Cho, et al.
Published: (2025-01-01)

Efficacy of low-dose rituximab versus immunosuppressants in refractory orbital inflammatory pseudotumors with intracranial extension
by: Yuyu Li, et al.
Published: (2025-01-01)

ENDOPROSTHESIS OF THE SHOULDER JOINT IN METASTATIC LESIONS OF THE PROXIMAL HUMERUS DURING IMMUNOSUPPRESSIVE THERAPY
by: M. V. Ivanova, et al.
Published: (2017-03-01)

Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group
by: Aysegul Oruc, et al.
Published: (2024-12-01)

Editorial: Pathogens at the interface of animals in close contact with humans: risks and benefits, with special regard to immunosuppressed people
by: Martina Jelocnik, et al.
Published: (2025-02-01)

The impact of HPV/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers
by: Terkimbi Dominic Swase, et al.
Published: (2025-02-01)

Protection Conferred by Gallid Alphaherpesvirus 2 Vaccines Against Immunosuppression Induced by Very Virulent Plus (vv+) Marek’s Disease Virus Strains in Commercial Meat Type Chickens
by: Nagwa Khaled, et al.
Published: (2025-01-01)

A mouse model of immunosuppression facilitates oral Candida albicans biofilms, bacterial dysbiosis and dissemination of infection
by: Raja Veerapandian, et al.
Published: (2025-01-01)

Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
by: Coraline Radermecker, et al.
Published: (2021-03-01)

Regulation of Stress-Induced Immunosuppression in the Context of Neuroendocrine, Cytokine, and Cellular Processes
by: Evgenii Balakin, et al.
Published: (2025-01-01)

Transient receptor potential channels in dental inflammation and pain perception: A comprehensive review
by: Varunya Chantadul, et al.
Published: (2025-01-01)

Effects of Rosa roxburghii & edible fungus fermentation broth on immune response and gut microbiota in immunosuppressed mice
by: Dechang Xu, et al.
Published: (2024-01-01)

Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
by: Qinyuan Gong, et al.
Published: (2025-01-01)

Cyclooxygenase-2/prostaglandin E2 inhibition remodulated photodynamic therapy-associated immunosuppression for enhanced cancer immunotherapy
by: Tao Xu, et al.
Published: (2025-04-01)

Corrigendum: Subtype-specific human endogenous retrovirus K102 envelope protein is a novel serum immunosuppressive biomarker of cancer
by: Qinyuan Gong, et al.
Published: (2025-01-01)

Uveitis in spondyloarthropathies: Current concepts
by: Krati Chauhan
Published: (2020-01-01)

The evolution of green finance research: A comprehensive bibliometric analysis
by: Guizhou Wang, et al.
Published: (2025-02-01)

TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response
by: Juntao Qi, et al.
Published: (2025-02-01)

The Importance of Monitoring Baseline and Regular Immunoglobulin Levels in Managing Secondary Hypogammaglobulinemia in Rheumatic Diseases: A Case Report and Systematic Review
by: Winnie Wan Yin Yeung
Published: (2024-12-01)

Novel 2,3-unsaturated O-glycosides containing an alkynyl function in their aglycones
by: Adriana C.N. de Melo, et al.
Published: (2025-01-01)

Unfavorable Tumor Responses to Immunotherapy in the Liver: Lessons Learned from Clinical and Preclinical Studies
by: Li-Chun Lu, et al.
Published: (2023-04-01)

Pro-inflammatory effects of inhaled Great Salt Lake dust particles
by: Jacob M. Cowley, et al.
Published: (2025-01-01)

Post Varicella Necrotising Fasciitis Afflicting Upper Limb in Young Child: A Rare Case Report
by: Swarup Prabhu, et al.
Published: (2024-03-01)

Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
by: Katharina Hogrefe, et al.
Published: (2025-01-01)